Utah Retirement Systems boosted its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 6.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 40,926 shares of the medical instruments supplier’s stock after purchasing an additional 2,600 shares during the period. Utah Retirement Systems’ holdings in Becton, Dickinson and were worth $7,985,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in BDX. BlackRock Inc. grew its position in Becton, Dickinson and by 2,427.8% during the 1st quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock worth $3,034,470,000 after purchasing an additional 15,887,611 shares during the last quarter. Vanguard Group Inc. grew its position in Becton, Dickinson and by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock worth $2,917,094,000 after purchasing an additional 796,034 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in Becton, Dickinson and during the 1st quarter valued at approximately $101,993,000. Waverton Investment Management Ltd acquired a new stake in Becton, Dickinson and during the 2nd quarter valued at approximately $68,448,000. Finally, Montag & Caldwell LLC lifted its stake in Becton, Dickinson and by 173.1% during the 2nd quarter. Montag & Caldwell LLC now owns 516,821 shares of the medical instruments supplier’s stock valued at $100,837,000 after acquiring an additional 327,587 shares during the period. 87.12% of the stock is currently owned by institutional investors.

Becton, Dickinson and Company (NYSE BDX) opened at 193.20 on Tuesday. The firm has a market capitalization of $41.02 billion, a PE ratio of 43.03 and a beta of 1.06. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $206.63. The company has a 50 day moving average of $199.01 and a 200 day moving average of $191.58.

Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm had revenue of $3.04 billion for the quarter, compared to analyst estimates of $3.06 billion. During the same period last year, the firm posted $2.35 EPS. Becton, Dickinson and’s quarterly revenue was down 5.1% on a year-over-year basis. Analysts forecast that Becton, Dickinson and Company will post $9.46 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be given a $0.73 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a yield of 1.51%. Becton, Dickinson and’s dividend payout ratio (DPR) is 83.43%.

Several brokerages have commented on BDX. Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a research note on Wednesday, August 9th. Cowen and Company restated a “buy” rating and set a $230.00 price objective on shares of Becton, Dickinson and in a research note on Monday, August 14th. Barclays PLC restated an “equal weight” rating and set a $210.00 price objective (up from $205.00) on shares of Becton, Dickinson and in a research note on Thursday, August 10th. BidaskClub upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a research note on Monday, August 14th. Finally, Wells Fargo & Company began coverage on shares of Becton, Dickinson and in a research note on Friday. They set an “outperform” rating and a $225.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. Becton, Dickinson and currently has a consensus rating of “Buy” and an average target price of $200.93.

In related news, insider Ellen R. Strahlman sold 9,283 shares of Becton, Dickinson and stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $198.21, for a total value of $1,839,983.43. Following the transaction, the insider now directly owns 26,638 shares in the company, valued at approximately $5,279,917.98. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Thomas E. Polen, Jr. sold 5,971 shares of Becton, Dickinson and stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the completion of the transaction, the insider now owns 12,861 shares in the company, valued at $2,538,890.01. The disclosure for this sale can be found here. Over the last quarter, insiders sold 75,904 shares of company stock worth $15,242,688. 1.40% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “Becton, Dickinson and Company (BDX) Shares Bought by Utah Retirement Systems” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/becton-dickinson-and-company-bdx-shares-bought-by-utah-retirement-systems/1588276.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.